Dragana Tomic from Naperville, IL, age 50

Us Patents

Method For Purifying Cancer-Specific Proliferating Cell Nuclear Antigen
view source
US Patent:

7723487, May 25, 2010
Filed:

Nov 13, 2007
Appl. No.:

11/983939
Inventors:

Linda H. Malkas - Indianapolis IN, US
Robert J. Hickey - Indianapolis IN, US
Pamela E. Bechtel - Tempe AZ, US
Min Park - Los Alamos NM, US
Derek J. Hoelz - Indianapolis IN, US
Dragana Tomic - Baltimore MD, US
Lauren Schnaper - Lutherville MD, US
Assignee:

CS-KEYS, Inc. - Indianapolis IN
International Classification:

C07K 16/00
US Classification:

5303877, 5303879
Abstract:

The method for developing an antibody that exclusively binds to csPCNA.

Method For Purifying Cancer-Specific Proliferating Cell Nuclear Antigen
view source
US Patent:

20100240874, Sep 23, 2010
Filed:

May 25, 2010
Appl. No.:

12/786782
Inventors:

LINDA H. MALKAS - INDIANAPOLIS IN, US
ROBERT J. HICKEY - INDIANAPOLIS IN, US
PAMELA E. BECHTEL - TEMPE AZ, US
MIN PARK - LOS ALAMOS NM, US
DEREK J. HOELZ - INDIANAPOLIS IN, US
DRAGANA TOMIC - BALTIMORE MD, US
LAUREN SCHNAPER - LUTHERVILLE MD, US
International Classification:

C07K 16/18
US Classification:

5303873, 5303879
Abstract:

An isolated antibody that binds a cancer specific Proliferating Cell Nuclear Antigen (csPCNA) that binds to the amino acid sequence LeuLysGlnLeuAspAlaGlnGlnThrGlnLeuArgIle AspSerPhePheArgLeuAlaGlnGlnGluLysGluAspAlaLysArg (SEQ ID No. 1). An immunoassay that utilizes an isolated antibody that binds a form of csPCNA that binds to the SEQ ID No. 1 to identify the presence of csPCNA in a sample.

Method For Purifying Cancer-Specific Proliferating Cell Nuclear Antigen
view source
US Patent:

7294471, Nov 13, 2007
Filed:

Feb 27, 2002
Appl. No.:

10/083576
Inventors:

Linda H. Malkas - Indianapolis IN, US
Robert J. Hickey - Indianapolis IN, US
Pamela E. Bechtel - Tempe AZ, US
Min Park - Los Alamos NM, US
Derek J. Hoelz - Indianapolis IN, US
Dragana Tomic - Baltimore MD, US
Lauren Schnaper - Lutherville MD, US
Assignee:

csKeys, LLC - Indianapolis IN
International Classification:

G01N 33/53
US Classification:

435 71, 435 72, 435 721, 435 723, 435 75, 435 77, 435 79, 435 791, 436518
Abstract:

A method for purifying cancer-specific Proliferating Cell Nuclear Antigen (csPCNA) is described, as well as an immunoassay based thereon.

Resumes

Dragana Tomic

view source

Dragana Tomic

view source

Medicine Doctors

Dr. Dragana Tomic, Cleveland OH - MD (Doctor of Medicine)

view source

Specialties:

Hematology
Medical Oncology
Oncology

Age:

Address:

CLEVELAND CLINIC FOUNDATION
9500 Euclid Ave, Cleveland, OH 44195
(216)4449083 (Phone), (216)4448575 (Fax)

Cadence Cancer Center
4405 Weaver Pkwy Suite 2, Warrenville, IL 60555
(630)6903414 (Phone)

Certifications:

Hematology, 2012
Internal Medicine, 2009
Medical Oncology, 2012

Awards:

Healthgrades Honor Roll

Languages:

English

Dragana Tomic

view source

Specialties:

Hematology/Oncology

Work:

Northwestern Medicine Regional Medical GroupNorthwestern Medicine Cancer Center
4405 Weaver Pkwy FL 2, Warrenville, IL 60555
(630)6903414 (phone), (630)3525499 (fax)

Education:

Medical School
Univ of Belgrade, Med Fak, Beograd, Serbia
Graduated: 1999

Procedures:

Chemotherapy

Conditions:

Anemia
Malignant Neoplasm of Female Breast
Hemolytic Anemia
Hodgkin's Lymphoma
Iron Deficiency Anemia

Languages:

English

Description:

Dr. Tomic graduated from the Univ of Belgrade, Med Fak, Beograd, Serbia in 1999. She works in Warrenville, IL and specializes in Hematology/Oncology. Dr. Tomic is affiliated with Central Dupage Hospital and Delnor Community Hospital.